Epilepsy and brain tumors;Épilepsie et tumeurs cérébrales

Revue Neurologique

Volumn 164, Issue 6-7, 2008, Pages 517-522

  Dupont, S ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Brain tumor; Epilepsy; Epileptogenesis; Prophylaxis; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; MULTIDRUG RESISTANCE PROTEIN;

BRAIN METASTASIS; BRAIN TUMOR; EPILEPSY; GLIOMA; HUMAN; PROPHYLAXIS; REVIEW; SEIZURE; ANIMAL;

ANIMALS; ANTICONVULSANTS; BRAIN NEOPLASMS; EPILEPSY; HUMANS;

EID: 45949102454     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2008.03.016     Document Type: Review

References (33)

1. Beaumont A., and Whittle I. The pathogenesis of tumour associated epilepsy. Acta. Neurochir. 142 (2000) 1-15
2. Boarini D., Beck D., and Vangilder J. Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 16 (1985) 290-292
3. Borg M., Probert J., and Zwi L. Is phenytoin contraindicated in patients receiving cranial irradiation?. Australas Radiol. 39 (1995) 42-46
4. Cascino G. Epilepsy and brain tumors: implications for treatment. Epilepsia 31 Suppl. 3 (1990) S37-S44
5. Chalk J., Ridgeway K., Brophy T., Yelland J., and Eadie M. Phenytoin impairs the bioavaibility of dexamethasone in neurological and neurosurgical patients. JNNP 47 (1984) 1087-1090
6. Foy P., Chadwick D., Rajgopalan N., Johnson A., and Shaw M. Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy?. J. Neurol. Neurosurg. Psychiatry 55 (1992) 753-757
7. Franceschetti S., Binelli S., Casazza M., Lodrini S., Panzica F., Pluchino F., et al. Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta. Neurochir. 103 (1990) 47-51
8. Gilmore R., Morris Hi, Van Ness P., Gilmore-Pollak W., and Estes M. Mirror focus: function of seizure frequency and influence on outcome after surgery. Epilepsia 35 (1994) 258-263
9. Glantz M., Cole B., Forsyth P., Recht L., Wen P., Chamberlain M., et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54 (2000) 1886-1893
10. Glantz M., Cole B., Friedberg M., Lathi E., Choy H., Furie K., et al. A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 46 (1996) 985-991
11. Hauser W.A., Annegers J.F., and Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota 1935-1984. Epilepsia 34 (1993) 453-468
12. Herman S. Epilepsy after brain insult: targeting epileptogenesis. Neurology 59 9 Suppl. 5 (2002) S21-S26
13. Hildebrand J., Lecaille C., Perennes J., and Delattre J. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65 (2005) 212-215
14. Hwang S., Lieu A., Kuo T., Lin C., Chang C., Huang T., et al. Preoperative and postoperative seizures in patients with astrocytic tumours: analysis of incidence and influencing factors. J. Clin. Neurosci. 8 (2001) 426-429
15. Kuijlen J., Teernstra O., Kessels A., Herpers M., and Beuls E. Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. Seizure 5 (1996) 291-298
16. Lee S., Lui T., Chang C., Cheng W., Wang D., Heimburger R., et al. Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures. Surg Neurol 31 (1989) 361-364
17. Lehmann D., Hurteau T., Newman N., and Coyle T. Anticonvulsivant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors. Clin. Pharmacol. Ther. 62 (1997) 225-229
18. Li X., Shu Q., Su J., Perlaky L., Blaney S., and Lau C. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4 and CMYC. Mol Cancer Ther 4 (2005) 1912-1922
19. Matthew E., Sherwin A., Welner S., Odusote K., and Stratford J. Seizures following intracranial surgery: incidence in the first post-operative week. Can J Neurol Sci 7 (1980) 285-290
20. Moots P., Maciunas R., Eisert D., Parker R., Laporte K., and Abou-Khalil B. The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52 (1995) 717-724
21. Neuwelt E., Kikuchi K., Lipsky P., and Frenkel E. Immune response in patients with brain tumors. Factors such as anti-convulsivants that may contribute to impaired cell-mediated immunity. Cancer 51 (1983) 248-255
22. North J., Penhall R., Hanieh A., Frewin D., and Taylor W. Phenytoin and postoperative epilepsy. A double-blind study. J. Neurosurg. 58 (1983) 672-677
23. Pace A., Bove L., Innocenti P., Pietrangeli A., Carapella C., Oppido P., et al. Epilepsy and gliomas: incidence and treatment in 119 patients. J. Exp. Clin. Cancer Res. 17 (1998) 479-482
24. Perry J., and Sawka C. Add-on therapy gabapentin for refractory seizures in patients with brain tumours. Can J. Neurol. Sci. 23 (1996) 128-131
25. Siddiqui A., Kerb R., Weale M., Brinkmann U., Smith A., Goldstein D., et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 348 (2003) 1442-1448
26. Tang R., Faussat A., Majdak P., Perrot J., Chaoui D., Legrand O., et al. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1. Leukemia 18 (2004) 1246-1251
27. Van Breemen M.S.M., Wilms E.B., and Vecht C.J. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 6 (2007) 421-430
28. van den Bent M. The role of chemotherapy in brain metastases. Eur J Cancer 39 (2003) 2114-2120
29. Vecht C., Wagner J., and Wilms E. Interactions between antiepilepticand chemotherapeutic drugs. Lancet Neurol. 2 (2003) 404-409
30. Wagner G., Wilms E., Van Donselaar C., and Vecht C. Levetiracetam: preliminary experience in patients with primary brain tumours. Seizures 12 (2003) 585-586
31. Wen P., and Marks P. Medical management of patients with brain tumors. Curr. Opin. Oncol. 14 (2002) 299-307
32. Wick W., Menn O., Meisner C., Steinbach J., Hermisson M., Tatagiba M., et al. Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long?. Onkologie 28 (2005) 391-396
33. Zaatreh M., Firlik K., Spencer D., and Spencer S. Temporal lobe tumoral epilepsy: characteristics and predictors of surgical outcome. Neurology 61 (2003) 636-641